MARKET WIRE NEWS
  1. Home
  2. Stock
  3. MESO
  4. News
MESO
Quote
Short
News
Articles
Message Board

Mesoblast Limited (NASDAQ : MESO ) News

Mesoblast Limited (NASDAQ: MESO) News Releases

MESO News Releases
MESO : NASDAQ
PR Newswire
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
MESO : NASDAQ
SeekingAlpha
Mesoblast misses H1 estimates
MESO : NASDAQ
SeekingAlpha
Mesoblast Limited (MESO) Q2 2026 Earnings Call Transcript
MESO : NASDAQ
GlobeNewswire
Ryoncil® Profits Underpinning Substantial Growth Pipeline
MESO : NASDAQ
GlobeNewswire
High Survival Rates With Ryoncil® in EIND Program Emphasize Importance of Earlier Use in Both Children and Adults With SR-aGvHD
MESO : NASDAQ
SeekingAlpha
Mesoblast: Real-World Data Validates The Bull Case For Ryoncil
MESO : NASDAQ
GlobeNewswire
Ryoncil® Net Revenues Increase for the Quarter to US$30M
MESO : NASDAQ
GlobeNewswire
Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
MESO : NASDAQ
GlobeNewswire
FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy
MESO : NASDAQ
SeekingAlpha
Mesoblast rises as Ryoncil sales climb 60% in December quarter

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.